JAGX RSI Chart
Last 7 days
-10.3%
Last 30 days
52.9%
Last 90 days
225%
Trailing 12 Months
-61.8%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2022 | 6.2M | 8.1M | 10.1M | 12.0M |
2021 | 0 | 0 | 0 | 4.3M |
2020 | 5.1M | 6.5M | 8.3M | 9.4M |
2019 | 5.2M | 6.0M | 5.9M | 5.8M |
2018 | 4.3M | 4.3M | 4.4M | 4.4M |
2017 | 925.8K | 1.8M | 2.8M | 4.4M |
2016 | 234.1K | 195.1K | 167.8K | 141.5K |
2015 | 0 | 0 | 0 | 258.4K |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Apr 05, 2024 | chaturvedi pravin r | acquired | - | - | 134 | chief scientific officer |
Apr 05, 2024 | wolin jonathan s. | acquired | - | - | 89.00 | chief of staff, cco & gc |
Apr 05, 2024 | lizak carol r. | acquired | - | - | 60.00 | chief financial officer |
Apr 05, 2024 | king steven r. | acquired | - | - | 178 | see remarks |
Apr 05, 2024 | conte lisa a | acquired | - | - | 600 | ceo and president |
Aug 14, 2023 | king steven r. | acquired | - | - | 159,168 | see remarks |
Aug 14, 2023 | conte lisa a | acquired | - | - | 383,605 | ceo and president |
Aug 14, 2023 | micek john | acquired | - | - | 68,568 | - |
Aug 14, 2023 | bochnowski james j | acquired | - | - | 76,613 | - |
Aug 14, 2023 | siegel jonathan b. | acquired | - | - | 68,568 | - |
Which funds bought or sold JAGX recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 16, 2024 | JANE STREET GROUP, LLC | added | 4,721 | 69,277 | 71,784 | -% |
May 15, 2024 | CITADEL ADVISORS LLC | sold off | -100 | -29,270 | - | -% |
May 15, 2024 | Royal Bank of Canada | reduced | -99.81 | - | - | -% |
May 15, 2024 | TWO SIGMA INVESTMENTS, LP | new | - | 2,340 | 2,340 | -% |
May 15, 2024 | TWO SIGMA SECURITIES, LLC | sold off | -100 | -9,425 | - | -% |
May 15, 2024 | Tower Research Capital LLC (TRC) | new | - | 5,340 | 5,340 | -% |
May 15, 2024 | BOOTHBAY FUND MANAGEMENT, LLC | unchanged | - | -3,061 | 4,475 | -% |
May 15, 2024 | BANK OF AMERICA CORP /DE/ | new | - | 21,574 | 21,574 | -% |
May 15, 2024 | MORGAN STANLEY | reduced | -96.38 | -6,872 | 151 | -% |
May 14, 2024 | ICA Group Wealth Management, LLC | new | - | 405 | 405 | -% |
Unveiling Jaguar Health Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Jaguar Health Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 50.9B | 6.8B | -8.53 | 7.44 | ||||
HILS | 22.5B | 216.3K | -2.5K | 104.0K | ||||
ALNY | 18.9B | 2.0B | -56.9 | 9.43 | ||||
BMRN | 14.7B | 2.5B | 71.65 | 5.96 | ||||
INCY | 12.8B | 3.8B | 17.2 | 3.4 | ||||
MID-CAP | ||||||||
BBIO | 5.6B | 107.9M | -10.31 | 48.09 | ||||
APLS | 5.0B | 524.1M | -12.02 | 9.57 | ||||
AXSM | 3.6B | 251.0M | -12.28 | 14.5 | ||||
ARWR | 3.1B | 240.7M | -6.53 | 12.77 | ||||
ACAD | 2.4B | 813.8M | -1.4K | 3 | ||||
SMALL-CAP | ||||||||
CPRX | 1.9B | 411.3M | 29.91 | 4.73 | ||||
NVAX | 1.8B | 996.6M | -4.58 | 1.83 | ||||
CRBP | 480.9M | 881.7K | -14.25 | 481.06 | ||||
INO | 310.9M | 4.9M | -2.49 | 63.89 | ||||
IBIO | 17.1M | 2.1M | -0.74 | 7.61 |
Jaguar Health Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 | 2018Q1 | 2017Q4 | 2017Q3 | 2017Q2 | 2017Q1 |
Revenue | - | - | - | - | - | - | 2,576,000 | 2,773,000 | 3,167,000 | 869,000 | 1,506,500 | 973,000 | 1,706,000 | 1,590,000 | 1,595,876 | 1,132,067 | 883,846 | 804,356 | 1,542,041 | 1,100,214 | 896,521 | 822,410 |
Cost Of Revenue | -19.2% | 495,000 | 613,000 | 456,000 | 455,000 | 469,000 | 789,000 | 784,000 | 1,031,000 | 676,000 | 743,000 | 948,000 | 1,260,000 | 865,000 | 956,828 | 736,733 | 608,024 | - | - | - | - | - |
Costs and Expenses | -26.8% | 9,546,000 | 13,046,000 | 9,400,000 | 14,379,000 | 12,907,000 | 7,743,000 | 8,148,000 | 11,618,000 | 8,523,000 | 7,330,500 | 7,700,000 | 12,328,000 | 7,365,000 | - | 7,638,279 | 7,962,920 | - | - | - | - | - |
Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | 7,364,841 | 13,706,297 | 7,638,279 | 7,962,920 | 5,932,617 | 22,223,157 | 8,440,303 | 3,246,774 | 4,698,012 |
S&GA Expenses | -17.1% | 1,748,500 | 2,109,000 | 2,144,000 | 2,835,000 | 2,300,500 | 1,881,000 | 1,529,000 | 1,730,000 | 1,469,000 | 1,500,000 | 1,698,000 | 2,173,000 | 1,565,000 | 2,712,372 | 2,716,752 | 2,690,262 | - | - | - | - | - |
R&D Expenses | -27.4% | 4,311,000 | 5,940,000 | 2,451,000 | 4,945,000 | 5,482,500 | 1,904,000 | 1,522,000 | 1,405,000 | 1,582,000 | 1,394,000 | 1,307,000 | 1,698,000 | 1,421,000 | 1,310,830 | 1,481,166 | 1,604,886 | - | - | - | - | - |
EBITDA Margin | 29.7% | -2.84 | -4.05 | -5.03 | -7.42 | -9.79 | -3.12 | -3.35 | -4.10 | -4.48 | -4.67 | -4.60 | -6.85 | -8.52 | -9.84 | - | - | - | - | - | - | - |
Interest Expenses | 7.9% | 2,948,000 | 2,731,000 | 2,536,000 | 4,194,000 | 2,433,000 | 1,533,000 | 581,000 | 479,000 | 199,000 | 174,000 | 1,353,000 | 3,657,000 | 547,000 | 442,817 | 872,044 | 711,802 | - | - | - | - | - |
Income Taxes | - | - | - | - | - | - | - | - | - | - | - | 10,000 | - | - | - | - | - | 19,344 | -990,549 | -12,190,693 | - | - |
Earnings Before Taxes | 34.7% | -8,232,000 | -12,609,000 | -9,390,000 | -18,164,000 | -14,318,000 | -8,769,000 | -7,866,000 | -9,238,000 | -7,936,000 | -5,959,000 | -7,545,000 | - | -8,304,000 | -12,653,885 | -6,138,352 | - | - | -21,198,007 | -7,430,849 | - | - |
EBT Margin | 25.3% | -4.05 | -5.42 | -6.64 | -9.42 | -12.13 | -3.60 | -3.73 | -4.71 | -5.88 | -5.97 | -5.91 | -8.02 | -9.28 | -10.74 | - | - | - | - | - | - | - |
Net Income | 39.4% | -7,581,000 | -12,520,000 | -9,367,000 | -17,986,000 | -14,318,000 | -8,769,000 | -7,866,000 | -9,238,000 | -7,936,000 | -5,959,000 | -7,555,000 | -16,721,000 | -8,304,000 | -12,653,885 | -6,138,352 | -7,657,183 | - | - | - | - | - |
Net Income Margin | 26.4% | -3.97 | -5.39 | -6.61 | -9.39 | -12.13 | -3.60 | -3.73 | -4.71 | -7.55 | -6.67 | -7.71 | -7.27 | -6.68 | -7.28 | - | - | - | - | - | - | - |
Free Cashflow | 24.7% | -6,423,000 | -8,532,000 | -10,457,000 | -7,695,000 | -8,923,000 | -4,061,000 | -2,919,000 | -4,002,000 | -4,303,000 | -3,140,000 | -8,547,000 | -5,305,000 | -3,465,000 | -4,902,078 | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | 9.1% | 55.00 | 51.00 | 45.00 | 52.00 | 57.00 | 47.00 | 51.00 | 50.00 | 53.00 | 53.00 | 59.00 | 70.00 | 69.00 | 43.00 | 36.00 | 38.00 | 33.00 | 36.00 | 36.00 | 36.00 | 41.00 |
Current Assets | 20.6% | 34.00 | 28.00 | 22.00 | 28.00 | 32.00 | 22.00 | 25.00 | 23.00 | 28.00 | 28.00 | 24.00 | 44.00 | 44.00 | 18.00 | 11.00 | 12.00 | 7.00 | 10.00 | 8.00 | 7.00 | 7.00 |
Cash Equivalents | 80.4% | 12.00 | 6.00 | 3.00 | 9.00 | 14.00 | 5.00 | 11.00 | 9.00 | 17.00 | 17.00 | 12.00 | 32.00 | 32.00 | 8.00 | 1.00 | 3.00 | 1.00 | 4.00 | 2.00 | 2.00 | 3.00 |
Inventory | -1.8% | 9.00 | 9.00 | 8.00 | 8.00 | 9.00 | 7.00 | 7.00 | 7.00 | 5.00 | 5.00 | 5.00 | 3.00 | 3.00 | 3.00 | 2.00 | 2.00 | 3.00 | 2.00 | 2.00 | 2.00 | 3.00 |
Net PPE | -2.4% | 0.00 | 0.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Liabilities | -10.4% | 41.00 | 46.00 | 44.00 | 46.00 | 49.00 | 49.00 | 48.00 | 47.00 | 45.00 | 41.00 | 38.00 | 38.00 | 37.00 | 26.00 | 28.00 | 25.00 | 17.00 | 16.00 | 15.00 | 29.00 | 25.00 |
Current Liabilities | 27.4% | 18.00 | 14.00 | 12.00 | 29.00 | 31.00 | 30.00 | 27.00 | 23.00 | 19.00 | 15.00 | 12.00 | 13.00 | 13.00 | 13.00 | 26.00 | 25.00 | 16.00 | 15.00 | 9.00 | 21.00 | 25.00 |
Shareholder's Equity | 141.3% | 12.00 | 5.00 | 1.00 | 6.00 | 8.00 | -1.36 | 4.00 | 3.00 | 8.00 | 12.00 | 22.00 | 32.00 | 32.00 | 17.00 | 8.00 | 2.00 | 6.00 | 11.00 | 11.00 | - | 7.00 |
Retained Earnings | -2.9% | -317 | -308 | -299 | -291 | -279 | -266 | -259 | -246 | -237 | -219 | -205 | -193 | -178 | -166 | -158 | -150 | -141 | -133 | -127 | -119 | -102 |
Additional Paid-In Capital | 5.0% | 330 | 314 | 301 | 298 | 287 | 267 | 263 | 250 | 246 | 231 | 227 | 225 | 211 | 184 | 160 | 151 | 146 | 142 | 138 | 118 | 110 |
Shares Outstanding | 588.6% | 159 | 23.00 | 21.00 | 18.00 | 5.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | -181.2% | -0.18 | -0.06 | 0.00 | 0.00 | 0.00 | -0.70 | -0.05 | 0.00 | 0.00 | 0.00 | - | - | - | - | - | - | - | - | - | - | - |
Float | - | - | - | - | 10.00 | - | - | - | 25.00 | - | - | - | 216 | - | - | - | 15.00 | - | - | - | 8.00 | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | 5.4% | -7,047,000 | -7,451,000 | -6,790,000 | -9,056,000 | -9,945,000 | -6,423,000 | -8,529,000 | -10,457,000 | -7,695,000 | -8,923,000 | -9,432,000 | -9,907,000 | -6,708,000 | -4,061,000 | -2,919,000 | -4,002,000 | -4,296,000 | -3,140,000 | -8,547,000 | -5,305,000 | -3,465,000 |
Share Based Compensation | 0.7% | 581,000 | 577,000 | 528,000 | 527,000 | 480,000 | 497,000 | 646,000 | 1,112,000 | 1,063,000 | 1,142,000 | 1,165,000 | 1,033,000 | 634,000 | 640,000 | 675,000 | 749,000 | 760,000 | 1,006,000 | 1,110,000 | 446,000 | 427,000 |
Cashflow From Investing | - | - | - | - | - | - | -361,000 | -56,000 | - | - | 10,478,000 | -10,478,000 | - | - | - | - | - | -7,000 | - | - | - | - |
Cashflow From Financing | 15.2% | 12,268,000 | 10,650,000 | 1,409,000 | 3,357,000 | 18,811,000 | 1,638,000 | 10,147,000 | 3,246,000 | 8,150,000 | 3,121,000 | 373,000 | 9,575,000 | 30,868,000 | 10,802,000 | 1,253,000 | 5,414,000 | 2,023,000 | 4,953,000 | 9,003,000 | 4,347,000 | 3,469,000 |
Buy Backs | - | - | - | - | - | - | - | - | - | - | - | 50.00 | - | - | - | 6.00 | - | - | - | - | - | - |
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Operating expenses | ||
Cost of product revenue | $ 430 | $ 345 |
Research and development | 4,312 | 4,775 |
Sales and marketing | 1,443 | 1,884 |
General and administrative | 4,381 | 4,813 |
Total operating expenses | 10,566 | 11,817 |
Loss from operations | (8,215) | (9,845) |
Interest expense | (611) | (2,181) |
Change in fair value of freestanding and hybrid financial instruments designated at Fair Value Option | (2,021) | (359) |
Gain on extinguishment of debt | 1,245 | |
Other income (expense) | 234 | (12) |
Loss before income tax | (9,368) | (12,397) |
Income tax expense | 0 | 0 |
Net loss | (9,368) | (12,397) |
Net loss attributable to noncontrolling interest | (142) | (195) |
Net loss attributable to common stockholders | $ (9,226) | $ (12,202) |
Net loss per share, basic | $ (0.06) | $ (2.39) |
Net loss per share, diluted | $ (0.06) | $ (2.39) |
Weighted-average common stock outstanding, basic | 158,842,297 | 5,109,609 |
Weighted-average common stock outstanding, diluted | 158,842,297 | 5,109,609 |
Product revenue, net | ||
Revenue | ||
Revenue | $ 2,351 | $ 1,972 |
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current assets: | ||
Cash | $ 11,671 | $ 6,469 |
Accounts receivable, net | 1,512 | 1,967 |
Other receivable | 202 | 217 |
Inventory | 9,020 | 9,189 |
Prepaid expenses and other current assets | 11,309 | 10,121 |
Total current assets | 33,714 | 27,963 |
Property and equipment, net | 484 | 496 |
Operating lease - right-of-use asset | 1,289 | 1,176 |
Intangible assets, net | 19,627 | 20,116 |
Other assets | 275 | 1,012 |
Total assets | 55,389 | 50,763 |
Current liabilities: | ||
Accounts payable | 3,320 | 4,974 |
Accrued liabilities | 3,461 | 3,798 |
Deferred revenue | 170 | |
Operating lease liability, current | 469 | 348 |
Notes payable, net of discount (includes note designated at Fair Value Option amounting to $10.2 million as of March 31, 2024 and $0 December 31, 2023, respectively) | 10,394 | 4,867 |
Total current liabilities | 17,814 | 13,987 |
Operating lease liability, net of current portion | 873 | 886 |
Deferred revenue - long term | 680 | |
Notes payable, net of discount, net of current portion (includes notes designated at Fair Value Option amounting to $21.7 million as of March 31, 2024 and $31.0 million December 31, 2023, respectively) | 21,719 | 30,993 |
Total liabilities | 41,086 | 45,866 |
Commitments and contingencies (See Note 6) | ||
Redeemable preferred stock: $0.0001 par value; 179 and 0 shares designated from 10,000.000 preferred stock authorized at March 31, 2024 and December 31, 2023; 99 and 0 shares issued and outstanding at March 31, 2024 and December 31, 2023 | 2,485 | |
Stockholders' equity | ||
Additional paid-in capital | 329,647 | 313,854 |
Noncontrolling interest | (180) | (64) |
Accumulated deficit | (317,215) | (308,248) |
Accumulated other comprehensive loss | (461) | (652) |
Total stockholders' equity | 11,818 | 4,897 |
Total liabilities, redeemable preferred stock and stockholder's equity | 55,389 | 50,763 |
Series G convertible preferred stock | ||
Stockholders' equity | ||
Preferred stock value | ||
Series H convertible preferred stock | ||
Stockholders' equity | ||
Preferred stock value | ||
Series I convertible preferred stock | ||
Stockholders' equity | ||
Preferred stock value | ||
Common stock - voting | ||
Stockholders' equity | ||
Common stock value | $ 27 | $ 7 |